These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24845798)

  • 1. Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma.
    Wang J; Taylor A; Showeil R; Trivedi P; Horimoto Y; Bagwan I; Ewington L; Lam EW; El-Bahrawy MA
    Cytokine; 2014 Aug; 68(2):94-100. PubMed ID: 24845798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
    BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of Vascular Endothelial Growth Factor Receptor Heterogeneity Identifies Protein Expression-defined Subclasses of Human Non-small Cell Lung Carcinoma.
    Holzer TR; Fulford AD; Reising LO; Nedderman DM; Zhang X; Benjamin LE; Schade AE; Nasir A
    Anticancer Res; 2016 Jul; 36(7):3277-88. PubMed ID: 27354584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
    Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
    Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    Goussia A; Simou N; Zagouri F; Manousou K; Lazaridis G; Gogas H; Koutras A; Sotiropoulou M; Pentheroudakis G; Bafaloukos D; Markopoulos C; Patsea H; Christodoulou C; Papakostas P; Zaramboukas T; Samantas E; Kosmidis P; Venizelos V; Karanikiotis C; Papatsibas G; Xepapadakis G; Kalogeras KT; Bamia C; Dimopoulos MA; Malamou-Mitsi V; Fountzilas G; Batistatou A
    PLoS One; 2018; 13(7):e0200302. PubMed ID: 30063723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
    Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
    Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells.
    Suzuki H; Watabe T; Kato M; Miyazawa K; Miyazono K
    Blood; 2005 Mar; 105(6):2372-9. PubMed ID: 15561887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma.
    Nasir A; Reising LO; Nedderman DM; Fulford AD; Uhlik MT; Benjamin LE; Schade AE; Holzer TR
    Anticancer Res; 2016 Jun; 36(6):2683-96. PubMed ID: 27272777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of VEGFR3 in glioma endothelium correlates with tumor grade.
    Grau SJ; Trillsch F; Herms J; Thon N; Nelson PJ; Tonn JC; Goldbrunner R
    J Neurooncol; 2007 Apr; 82(2):141-50. PubMed ID: 17115285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
    Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
    Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
    Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
    PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.